Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Friday, February 28th, 2025

Parkway Life REIT: Steady Growth Amid Strategic Expansion and Robust Capital Management

Broker Name: OCBC Investment Research
Date: 21 October 2024


Investment Rating

  • Rating: BUY (as of 21 October 2024)
  • Last Close: SGD 3.99
  • Fair Value Estimate: SGD 4.48
  • Parkway Life REIT (PLIFE) maintains a stable outlook amidst challenging market conditions. The REIT’s strong fundamentals and strategic capital management make it a favorable option for long-term investors.

Recent Financial Performance

  • 9M24 Distribution per Unit (DPU): Grew by 2.8% year-on-year (YoY) to 11.3 Singapore cents. Despite the depreciation of the Japanese yen (JPY), distributable income was safeguarded through JPY net income hedges.
  • Gearing: Increased to 37.5% as of 30 September 2024, following the acquisition of a nursing home in Osaka, Japan. However, the all-in cost of debt remains low at 1.36%.
  • Gross Revenue and Net Property Income (NPI): For 9M24, gross revenue and NPI declined by 2.2% and 2.1% YoY, respectively. The JPY depreciation was partially offset by new contributions from acquired nursing homes in Japan and rental step-ups.
  • Distributable Income: Amounted to SGD 68.3 million for 9M24, translating to a DPU of 11.3 Singapore cents (or 3.76 Singapore cents for 3Q24). This meets 73.7% of the full-year DPU forecast.

Investment Thesis

PLIFE is one of Asia’s largest listed healthcare REITs, with a robust portfolio of 64 healthcare assets across Singapore, Malaysia, and Japan. The REIT is known for its long-term lease structures, offering stability and growth potential through rental escalations and acquisitions.

  • Defensive Sector: Healthcare REITs are typically defensive, with PLIFE benefitting further from its diversified healthcare assets.
  • Portfolio: Comprises private hospitals and medical centers in Singapore and Malaysia, and nursing homes in Japan, totaling a portfolio valuation of SGD 2.25 billion as of 30 September 2024.
  • Growth Potential: Continued potential for growth supported by trends such as increasing foreign medical tourism in Singapore and an aging population in Japan.

Capital Management

  • Gearing and Debt Management: Gearing rose slightly due to recent acquisitions but remains manageable at 37.5%. About 87% of interest rate exposure is hedged, and the all-in cost of debt is stable at 1.36%.
  • Loan Refinancing: The REIT has refinanced maturing loans due in 2025, including a short-term loan linked to recent acquisitions. This extends the weighted average debt term to 3.8 years, with no significant refinancing needed until September 2026.

Valuation and Performance

  • Current Valuation: Trading at a forward 12-month price-to-book (P/B) ratio of 1.6x and a forward dividend yield of 3.7%, which are below and above the five-year historical averages, respectively.
  • Investment Outlook: Long-term investors can consider buying on price pullbacks ahead of anticipated significant DPU growth, particularly after 2026, when renovation works at Mount Elizabeth Hospital are completed.

ESG Overview

  • ESG Rating: Maintained as of December 2023. Although PLIFE actively promotes energy conservation, the proportion of green-certified buildings remains limited. Corporate governance could be improved with more independent board members.
  • Business Ethics: A robust framework, including whistleblower protection, positions PLIFE ahead of many global peers.

Key Risks

  • Interest Rates and Funding Costs: High interest rates could affect distributable income, impacting growth prospects.
  • Tenant Issues: Risks include tenant defaults or refusal to renew leases, particularly in Japan.
  • Cost Overruns: Potential overruns from capital expenditure programs or asset enhancement initiatives.

Future Catalysts

  • Accretive Acquisitions: Further growth through acquisitions that enhance the DPU.
  • Japanese Yen (JPY) Dynamics: A hawkish Bank of Japan (BoJ) could strengthen the JPY, which would positively impact PLIFE’s income.
  • Rental Upside: Higher-than-expected performance of Singapore assets or successful renegotiation of Japan leases could drive additional revenue.

Conclusion

Parkway Life REIT continues to exhibit robust growth and stability. With a strategic approach to acquisitions, prudent debt management, and resilience in a defensive sector, it remains a solid investment for those seeking long-term income stability.

PGF Capital Gains Momentum with Positive Technical Indicators

Date: October 21, 2024Broker: CGS International Securities Malaysia Sdn. Bhd. Company Overview PGF Capital is a diversified company engaged in various business segments, including manufacturing, construction, and investment. The company focuses on delivering quality...

What is the target price for Samudera?

Samudara has just broken a “Bullish Falling Wedge Chart Pattern” designed by Minichart as it is a bullish formation, and the price will rise from here. There are a few reasons why the uptrend...

Singapore Market Outlook: FSSTI Rises 0.4%, DBS Leads Institutional Buying

Comprehensive Analysis of FSSTI Index and Featured Companies Comprehensive Analysis of FSSTI Index and Featured Companies Broker Name: Lim & Tan Securities Date of Report: 12 November 2024 Financial Markets Overview U.S. stocks ended...